#LifeSciences@papercurve 2.0 is here and it's only the beginning. With one license, get remote collaboration, content management, secure file storage, and regulatory compliance.
https://t.co/5CS0WHRZLI
Next week I’m excited to be speaking on the DMZ stage @CollisionHQ! Join me at @dmzhq’s booth, E281, on June 28th at 3:30p where I’ll be sharing insights on Papercurve's Human-Centered Approach to AI. Learn more: https://t.co/eC5aSRyKqZ
It’s @ Collision’s biggest year yet! I’m excited to be speaking on the DMZ stage.
Join me at DMZ’s booth, E281, on June 28th at 3:30pm where I’ll be sharing insights on a Papercurve's human-centered approach to AI!
https://t.co/X78TVVbAug
See how @Papercurve compares to Veeva Vault. Get teams adopting compliant review processes faster and contact us on how we help save on average 8x in costs: https://t.co/LoW3OFaJ8q
Our @Papercurve product suite has evolved by listening directly to our users through our Customer Success teams to create the right solutions you need.
We are pleased to announce the launch of Papercurve 2.0 on October 19th 2022!
https://t.co/Q1ALp0oiVo
@ParkerLeib Check out @Papercurve if you have a chance. We came from healthcare and are very familiar with your frustrations. We develop software with ease of use, stickiness, in mind. You don't need hours of training to use it, in the event you need help, we have dedicated customer support!
@Just_PCEW Just came across this tweet and wanted to say that we lived through your pain before! Founded @Papercurve to fix the issues. I hope you don't have to deal with bad software in the future. If you get a chance check us out :)
@chrisleiter_@brandonhli@morgancheatham Agree! We founded @Papercurve because we lived this pain in pharma. Our core values consists of ensuring that our platform is intuitive, and if you do need training we provide that for free with a dedicated customer success representative. Software shouldn't hold us hostage.
For the $$ that @webflow charges, we are at a point where we can't load our website in designer, contacted support no response, and backup restoration times out. What are we doing here in 2022 trusting companies like @webflow when it's easier to just write html, css, javascript?
The time is near! Come visit me at the Papercurve booth - B3117 - Thursday June 23rd at the Collision Conference in Toronto! I will also be at the conference the entire week, let's connect irl. #CollisionConf#Toronto
https://t.co/p7jEKLwwHO
If you're planning on going to the Collision conference, let's connect.
Papercurve will have a booth, and it will mark our second time being accepted into Collision's startup program.
https://t.co/AZTpwcSZo7
We have released a lot of new products/solutions for the #LifeScience industry.
It was time that @Papercurve's website reflected these changes so check out the newly designed https://t.co/QST8otXxTF
#mlr#prc#biotech
Check out @Papercurve CEO speak at the @ScimaxGlobal MI-Tech annual forum next week. We have some big announcements coming up with our Papercurve’s Paige AI product. Register to get a sneak peak.
https://t.co/T5NA9JJ1Hx
Papercurve designs enterprise software with a focus on the user.
In order to do this we analyze usage in many ways. Check out what we've found when analyzing the collaboration between users in review teams.
https://t.co/ymk4OiPbTF
Papercurve’s Paige AI is able to recommend references for medical affairs by utilizing NLP.
The benefits here allow our users to process reviews faster and even retain information on the platform for other users to leverage in the future.
https://t.co/D5EmE8DFuk
Papercurve's Customer Success and Product team strives to have high touch points with our clients in the Life Sciences. It differentiates our roadmap to help delivery value quickly and in line with GxP standards and compliance.
https://t.co/mjdKJZcry2
The best reward is when our team receives feedback that aligns with our vision of revamping an industry with innovative approaches to product design and customer success.
Thank you to our partners and kudos to the Papercurve team!
https://t.co/dejhxAxkk2